FDA expands blood pressure drug recall, again
The Food and Drug Administration is again expanding its recall of widely prescribed blood pressure drugs due to contamination with a cancer-linked chemical.
Monday's announcement targets an additional five lots of the generic drug losartan made by Torrent Pharmaceuticals Limited. The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets.
The recalled lots contain trace amounts of N-methylnitrosobutyric acid, or NMBA, which has been linked to cancer.
This is the fifth time in 2019 that Torrent Pharmaceuticals has expanded its voluntary recall of losartan. The recall was first announced in January.
Losartan is a generic angiotensin II receptor blocker, or ARB, and is used to treat high blood pressure as well as heart failure. Over the last year, scores of batches of generic ARBs have been withdrawn from the market due to the presence of chemical contaminants called nitrosamines, which have been linked to an increased risk of certain kinds of cancer.
Federal health officials said a recall for medication used to treat high blood pressure has been expanded for a fifth time after trace amounts of a possible cancer-causing substance were detected. Torrent Pharmaceuticals Limited announced its
Torrent Pharmaceuticals Limited is once again expanding its voluntary recall of contaminated sartans to include three more lots of losartan potassium and two more lots of losartan-hydrochlorothiazide combination tablets. The nationwide recall, to the consumer level,
Blood pressure medicine from Torrent Pharma has been recalled for the fifth time after trace amounts of the cancer-causing impurities were found in the pills. Three lots of Losartan Potassium tablets and two lots of
A recall of certain blood pressure medications expanded after tests found a potentially cancer-causing chemical, according to the Food and Drug Administration. The FDA reports that some lots of Torrent Pharmaceuticals Limited's Losartan Potassium Tablets USP
Interruptions continue to wreak havoc on the global drug supply as drugmakers respond to the detection of impurities that are produced during manufacturing of some commonly used prescription and over-the-counter meds. India's Dr. Reddy's joined
Torrent Pharmaceuticals Limited has expanded its voluntary recall of losartan potassium tablets after finding trace amounts of an "unexpected impurity." The expanded recall includes an additional three lots of losartan potassium tablets USP and two
The Food and Drug Administration has again expanded a recall for medication used to treat high blood pressure. Torrent Pharmaceutical Limited is recalling certain lots of Losartan Potassium tablets. The medication is used to treat hypertension,
More News in Health
For the second time in five years, Wake Forest Baptist Health has been recognized for its expertise in conducting innovative cancer care research by the National Cancer Institute's Community Oncology Research Program (NCORP) with a
CHARLESTON, S.C. - In letters to students, faculty and staff on Monday, Sept. 23, The College of Charleston reported an outbreak of mumps at the school. Three cases of the disease were diagnosed over the
Nashville, Tenn.-based HCA Healthcare has selected Jennifer Berres to serve as senior vice president and chief human resource officer, effective Nov. 1. Ms. Berres is currently vice president of human resources business partners and HR
Berres will replace 25-year company veteran Steele Nashville-based HCA Healthcare has promoted longtime human resources executive Jennifer Berres to senior vice president and chief human resource officer, effective Nov. 1. She will replace 25-year
Patricia Shaw, a 77-year-old Connecticut woman, died last week from Eastern Equine Encephalitis (EEE), a rare mosquito-linked illness. Speaking to WFSB at a vigil for Shaw on Saturday, Rev. Brian Maxwell of Saint Matthias of East